Drug Shortage Report for APO-QUINAPRIL/HCTZ
Report ID | 133994 |
Drug Identification Number | 02408767 |
Brand name | APO-QUINAPRIL/HCTZ |
Common or Proper name | QUINAPRIL/HCTZ |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | QUINAPRIL HYDROCHLOROTHIAZIDE |
Strength(s) | 10MG 12.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 BLS |
ATC code | C09BA |
ATC description | ACE INHIBITORS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-02-11 |
Estimated end date | 2021-05-14 |
Actual end date | 2021-05-07 |
Shortage status | Resolved |
Updated date | 2021-05-10 |
Company comments | 100 BTL format remains available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-05-10 | French | Compare |
v3 | 2021-05-10 | English | Compare |
v2 | 2021-02-12 | French | Compare |
v1 | 2021-02-12 | English | Compare |
Showing 1 to 4 of 4